Ibaraki, Japan

Yasuko Horikoshi


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Ibaraki, JP (2006 - 2010)
  • Tsukuba, JP (2010)

Company Filing History:


Years Active: 2006-2010

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Yasuko Horikoshi: Pioneering Innovations in Antibody Research

Introduction

Yasuko Horikoshi, an inventor based in Ibaraki, Japan, has made significant contributions to the field of biomedical research, particularly through her work on innovative antibodies. With a notable portfolio of four patents, her research focuses on developing diagnostic agents that can be utilized in detecting various medical conditions.

Latest Patents

Among Horikoshi's latest innovations are two groundbreaking patents. The first, titled "Anti-metastin antibody and its use," presents an antibody that can specifically quantify metastin or its derivatives with high sensitivity. It outlines a method for detecting and quantifying metastin using this antibody, which holds potential as a diagnostic tool, including applications for pregnancy testing.

The second patent, "ZAQ ligand-1 antibodies and uses thereof," describes an antibody with exceptional binding ability to human ZAQL-1. This antibody not only neutralizes ZAQL-1 activity but also inhibits its effects, offering valuable therapeutic and diagnostic potential for a range of health issues, including digestive diseases, mental health disorders, and various conditions associated with aging.

Career Highlights

Yasuko Horikoshi is affiliated with Takeda Pharmaceutical Company Limited, where she engages in cutting-edge research and development. Her contributions have helped propel the company to the forefront of innovation in the pharmaceutical industry, particularly in the area of antibody therapies.

Collaborations

Throughout her career, Horikoshi has collaborated with esteemed colleagues such as Hirokazu Matsumoto and Tetsuya Ohtaki. These collaborations have been instrumental in advancing her research and expanding the scope of her inventions, fostering a culture of innovation within her team.

Conclusion

In conclusion, Yasuko Horikoshi exemplifies the spirit of innovation through her dedication to advancing medical research and developing antibodies that have the potential to transform diagnostics and treatments. Her work at Takeda Pharmaceutical Company Limited continues to set the stage for future breakthroughs, marking her as a key figure in the realm of biomedical inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…